In The mixture therapy arm, escalating doses of ABBV-CLS-579 is going to be supplied together with a PD-1 inhibitor. Grownup individuals which has a prognosis of some solid tumors for which no productive regular therapy exists, or has failed are going to be enrolled. A promising anabolic DMOAD is